The use of copyright vaporizers in Australia represents a difficult and developing legal and medical landscape. Currently, Dimethyltryptamine is a scheduled substance country-wide, meaning its possession and sale are strictly fined under federal law. While vaporizing this compound presents unique hazards beyond those associated with traditional sub